Large Cap Archives - Page 3 of 437

2 minute read

Teva Engages In Settlement Talks Over Medicare Kickback Allegations

June 18, 2:24 PM

Teva Pharmaceutical is negotiating with the DOJ to settle a lawsuit alleging it paid kickbacks through charities to boost Copaxone sales, risking up to $10 billion in damages.

TEVA

2 minute read

Obesity In Children – US Parents Face Tough Time To Access Recommended Treatment, Though Novo Nordisk’s Drug Still Sees Strong Demand

By Vandana Singh

June 18, 12:30 PM

U.S. parents face significant barriers to accessing intensive behavioral counseling for childhood obesity, with programs often unavailable, not covered by insurance, and requiring substantial time commitments.

NVO

1 minute read

Medicare Agency To End Advance Payments Following UnitedHealth Cyberattack

By Vandana Singh

June 18, 10:52 AM

The CMS will end the advance payments program for Medicare providers and suppliers affected by the UnitedHealth Change Healthcare hack. This program, initiated in March, has disbursed over $3.27 billion. Applications close July 12.

UNH

2 minute read

Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical’s $1.3B Deal

By Vandana Singh

June 18, 10:02 AM

Boston Scientific to acquire Silk Road Medical for $1.26 billion, enhancing its vascular portfolio with Silk Road's TCAR system, a breakthrough in stroke prevention. Transaction closes in H2 2024.

BSX

2 minute read

AstraZeneca’s Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial

By Vandana Singh

June 18, 9:22 AM

AstraZeneca announced that the CAPItello-290 Phase 3 trial for Truqap (capivasertib) combined with paclitaxel in advanced or metastatic triple-negative breast cancer did not meet primary endpoints for overall survival.

AZN

2 minute read

FDA Approves Merck’s Pneumococcal Vaccine As First Shot Designed For Adults

By Vandana Singh

June 18, 8:05 AM

The FDA has approved Merck's Capvaxive, the first pneumococcal conjugate vaccine for adults, protecting against 21 strains of bacteria. Additionally, Merck's Keytruda received FDA approval for advanced endometrial carcinoma.

MRK

2 minute read

Qiagen Unveils Plan For $1B Shareholder Returns, Major Product Launches

By Vandana Singh

June 17, 3:04 PM

QIAGEN announces a comprehensive growth strategy by 2028. The plan includes significant shareholder returns, new product launches, and a focus on digital and diagnostic advancements.

QGEN

1 minute read

Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday?

By Vandana Singh

June 17, 1:22 PM

BioNTech partner MediLink Therapeutics faces a partial clinical hold from the FDA on the Phase 1 trial of BNT326/YL202 for advanced non-small cell lung cancer and HR+/HER2-negative breast cancer.

BNTX

2 minute read

Pfizer’s COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading Claims

By Vandana Singh

June 17, 1:13 PM

Kansas has filed a lawsuit against Pfizer, Inc., alleging the company misled the public about the safety and effectiveness of its COVID-19 vaccine, resulting in consumer protection violations and record revenues.

PFE